Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nordea Bank Abp: Repurchase of own shares on 27.09.2022

Nordea Bank AbpStock exchange release – Changes in company’s own shares27.09.2022 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 27.09.2022 completed repurchases of own shares (ISIN: FI4000297767) as follows: Trading Number of Weighted average Total cost, EUR* **venue (MIC shares price / share, EUR* Code) **XHEL 677,313 9.22 6,244,216.28CEUX 407,016 9.20 3,746,438.90TQEX 54,972 9.20 505,535.99XSTO 320,213 9.18 2,

Multiconsult ASA - Share buyback

Multiconsult ASA (OSE: MULTI) announced on 19. September 2022 a non-discretionary agreement with ABG Sundal Collier for the repurchase of up to 500,000 of its ordinary shares in the market in connection with its employee share purchase programme in 2022.From 19. September 2022 until 27. September 2021, Multiconsult ASA has purchased a total of 19,298 own shares at Oslo Børs at an average price of NOK 134.8408 per share. Aggregated overview of transactions per day: Overview oftransactionsDate Aggregated daily Weighted average Total daily volume (

New Hearts of Iron IV Expansion Available Now

By Blood Alone Add-On Includes Plane Designer and New Alternate HistoriesSTOCKHOLM - 27 September 2022 - Paradox Interactive’s best-selling grand strategy wargame Hearts of Iron IV gets even grander and more strategic today with the release of By Blood Alone, a new expansion pack that adds new ways to explore the limits of your military genius and long-term planning. The centerpieces of By Blood Alone include the much requested aircraft designer, allowing you to build the fighters and bombers of your imagination, and three new national focus trees, carving out room for an even wider

AcuCort receives marketing authorization for the drug Zeqmelit by the Norwegian Medicines Agency

AcuCort AB (publ) (Spotlight Stock Market: ACUC) today announces that the Norwegian Medicines Agency, Statens legemiddelsverk, has approved the company’s first drug under the name Zeqmelit in Norway.In the development of the drug Zeqmelit/ISICORT[®], AcuCort has managed to combine the benefits of the well-proven substance dexamethasone and the patented user-friendly oral film for quick availability and relief in emergency situations such as severe and acute allergic reactions. The drug was recently approved in Denmark under the name Zeqmelit and has previously been approved in Sweden

As previously communication, Brighter's subsidiary Nectarine Health has now submitted an application for corporate restructuring

Brighter AB (Publ) (“Brighter”) announces that its subsidiary Pink Nectarine Health AB (“Nectarine Health”) has today, as communicated in a press release from September 23 2022 , submitted an application for corporate restructuring (Sw. “företagsrekonstruktion”) to the Stockholm District Court. The decision follows from a liquidity shortfall in Nectarine Health and is deemed necessary to give Nectarine Health the time required to

International Energy Summit Reflects the Change in Energy Dynamics

The Association of International Energy Negotiators (AIEN) announces its International Energy Summit (previously the International Petroleum Summit), to be held from September 27-29, 2022, at the Hilton on Park Lane Hotel in London, UK.The AIEN has adapted to the shifting priorities of its members and the need for energy security and energy transition. The International Energy Summit will reflect this changing landscape within the industry. J. Scott Porter, 2022‐2023 AIEN President, comments: “There is a clear shift in the energy industry. AIEN is a non-profit organization which

Configura Develops New Epic Games’ Twinmotion Extension for CET to Simplify Visual Communication

Configura users can now see their designs come to life using Twinmotion to create high-end visuals and immersive experiences.GRAND RAPIDS, MICH., USA—Sept. 27, 2022—Configura, in collaboration with Epic Games, a leading interactive entertainment company and provider of 3D engine technology, announces availability of a new Extension to advance users’ CET experience. The latest CET Extension, Twinmotion , allows users to easily create quicker and more realistic renderings. To make sure users are staying ahead in the global market, Configura recognizes

ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 27.09.2022

ALEXANDRIA PANKKIIRILIIKE OYJ NOTIFICATION    27.09.2022 at 18:30 EET   ALEXANDRIA PANKKIIRILIIKE OYJ: ACQUISITION OF OWN SHARES 27.09.2022   Date 27.09.2022  Exchange transaction Buy  Share class ALEX  Amount 300  Average price/share 6.1200   EURHighest price/share 6.1200   EURLowest price/share 6.1200   EURTotal price 1,836.00 EUR        The shares held by Alexandria Pankkiiriliike Oyj on 27.09.

FISKARS CORPORATION: ACQUISITION OF OWN SHARES 27.09.2022

Fiskars Corporation   Stock Exchange Release 27.09.2022 at 18:30 EET/EEST   FISKARS CORPORATION: ACQUISITION OF OWN SHARES 27.09.2022   Date 27.09.2022  Exchange transaction Buy  Share class FSKRS  Amount  9,400  Average price/share 15.0452 EURHighest price/share 15.1000 EURLowest price/share 14.9400 EURTotal price 141,424.88 EUR        The shares held by Fiskars Corporation on 27.09.2022   FSKRS 1,175,953       On

UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 27.09.2022

United Bankers Plc NOTIFICATION   27.09.2022 at 18:30   UNITED BANKERS PLC: ACQUISITION OF OWN SHARES 27.09.2022   Date 27.09.2022  Exchange transaction Buy  Share class UNITED  Amount 20  Average price/share 13.2500 EURHighest price/share 13.2500 EURLowest price/share 13.2500 EURTotal price 265.00 EUR        The shares held by United Bankers Plc on 27.09.2022:   UNITED 60,758         On behalf of United

Construction permit application submitted for Enviro’s planned facility in Uddevalla

Scandinavian Enviro Systems AB (publ) ("Enviro", "the company") has submitted an application for a construction permit through the property owner, Fratera, for the planned recycling plant in Uddevalla, Sweden.The construction permit application pertains to the previously announced recycling plant that the company plans to establish on an industrial site in the Lillesjö district of Uddevalla Municipality. The application follows the environmental permit for the planned facility, which was granted to Enviro in June of this year, and which was also previously announced by the company. The

AAK signed a green loan of SEK 500 million

AAK AB (publ.) has signed a bilateral green loan of SEK 500 million structured by Mizuho Bank, Ltd. The loan has a duration of 3 years.  The loan is closely linked to AAK’s sustainability targets and commitment to accelerate its reduction of greenhouse gas emissions and will be used for the previously communicated investment in biomass boilers at the AAK production plant in Aarhus, Denmark.The bio boilers are expected to reduce the plant’s CO₂ emissions by approximately 90 percent. They will also generate substantial savings as fossil fuel will be replaced by shea meal, a by-product of

#22-337 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#22-336 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

CS MEDICA intensifies its presence on Amazon platforms

CS MEDICA A/S (”CS MEDICA” or the ”Company”) sells their Cannasen® CBD product line on Amazon Germany and Amazon Sweden, but is not experiencing the uplift in sales as expected. Henceforward CS Medica is intensifying their presence on Amazon platforms and has entered a cooperation with Incubeta, an Amazon service provider specialized within CBD products.CS MEDICA is selling its Cannasen[®] CBD brand on Amazon Germany and Amazon Sweden but is not experiencing the sales uplift as expected. Hence, the roll-out to France, Italy, and other countries has been on hold. To intensify the company'

Eagle Filters Oy corporate restructuring program has ended

Loudspring Oyj Company release 27 September 2022 at 17:00 (EET) Eagle Filters Oy corporate restructuring program has ended  Loudspring reported earlier that its 100% owned subsidiary Eagle Filters has paid all remaining payments of the debts of its corporate restructuring program in advance to the repayment schedule. Eagle Filters then applied for the premature termination of the program, and the program has now ended. The program lasted for over six years.   Loudspring CEO Jarkko Joki-Tokola: We are happy to announce the end of Eagle Filters' corporate restructuring program.

Glycorex Transplantation (GTAB B): Glycosorb[®] ABO used at the largest heart transplant center in Germany

Today, the Herz- und Diabeteszentrum Nordrhein-Westfalen in Bad Oeynhausen has announced in a press release  that their first blood group incompatible heart transplant using Glycosorb® ABO has been performed and with excellent results. The transplant was performed on a two-year-old girl, and she has now been able to celebrate her two-year-old birthday at home. The girl came to the hospital five months ago as a result of an incurable genetic heart muscle disease

Brighter publishes supplementary prospectus

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, AUSTRALIA, HONGKONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Brighter AB (publ) (“Brighter” or the “Company”) has established a supplement (the "Supplementary Prospectus") in addition to the EU growth prospectus regarding subscription of units in the ongoing rights issue (the “Rights Issue”) that

Kwiff Joins Forces with Xtremepush to Power Player Outreach Strategy

Kwiff , the super-charged betting service, has partnered with global Multi-Channel Experience and Engagement Marketing provider Xtremepush.This agreement allows kwiff to add even more momentum to its progressive player outreach strategy which forms an integral role in the company’s growth. kwiff’s engagement and retention strategy is executed through communicating with players in a highly personalised and timely manner.  Working with Xtremepush has shaped kwiff’s strategy by utilising personalised notifications for games or events that are relevant to them based on

BERGENBIO ANNOUCES FIRST PATIENT RANDOMIZED IN BEMCENTINIB TRIAL IN EU-SOLIDACT PLATFORM FOR HOSPITALIZED COVID-19 PATIENTS

BERGEN, Norway, September 27, 2022 – BerGenBio ASA (OSE: BGBIO), a clinical-stage biopharma-ceutical company developing novel, selective AXL kinase inhibitors for severe unmet medical needs, and Oslo University Hospital announced today that the first patient has been included in a study of BerGenBio’s oral, highly selective AXL inhibitor, bemcentinib, as part of the EU-SolidAct trial in hospitalized COVID-19 patients.   The EU-SolidAct trial (European DisCoVeRy for Solidarity: An Adaptive Pandemic and Emerging Infection Platform Trial) is part of EU-RESPONSE, a pan-European research

Sivers Semiconductors receives purchase orders of 900 kUSD (10 MSEK*) from European satellite communications company

Sivers Semiconductors AB (“Sivers”) today announces that its business unit, Sivers Wireless, has received purchase orders for engineering activities (750 kUSD) and acceleration fees (150 kUSD) to speed up manufacturing of beamformer ICs at a total value of 900 kUSD (approximately 10 MSEK*).The engineering activities have started for this new project. The acceleration fee purchase order is a consequence of an ongoing development contract from MixComm, a company acquired by Sivers and now integrated in Sivers Wireless. The first generation beamformer ICs have been developed during the last

Nokian Tyres: Disclosure under chapter 9, section 10 of the securities market act

Nokian Tyres plc Stock Exchange Release September 27, 2022 at 3:50 p.m. Nokian Tyres has received an announcement from BlackRock, Inc. on September 27, 2022, in accordance with the Finnish Securities Market Act Chapter 9, Section 5. According to the announcement, the indirect holding in Nokian Tyres shares owned by BlackRock, Inc. and its funds fell below the level of 5% of the share capital of Nokian Tyres plc, as a result of share transactions concluded on September 26, 2022. Total positions of BlackRock, Inc. and its funds subject to the notification: +----------------+----------

Lipum gets approval to start Phase 1 clinical trial with drug candidate SOL-116

Press release: Umeå, 27 September, 2022. Lipum AB (publ) announces today that the CTA (clinical trial application) for the drug candidate SOL-116 has been approved by the regulatory authorities in The Netherlands.The study that includes healthy volunteers and patients with rheumatoid arthritis will be carried out at QPS BV facility in Groningen, Netherlands. The study will be conducted as a dose escalation study by beginning with a very low dose and then gradually increasing the dose. The study is planned to start in October. “As planned, the clinical trial application has been approved

Ruter expands collaboration with Nobina by exercising option for additional electric buses

Ruter has chosen to expand its collaboration with Nobina in conjunction with the exercise of an option for 14 electric articulated buses to operate on route 23 between Lysaker and Simensbråten. The option is an addendum to the contract secured by Nobina in June 2022, when Nobina secured a renewed and extended contract to operate and develop city transport services in Oslo and the surrounding areas.The option for 14 scheduled electric articulated buses means route 23 will be fully electrified when services begin operating in December 2023, and is part of Nobina’s promise to always provide

There are no items matching the current filter
There are no more items matching the current filter
Back to top